tiprankstipranks
Alkermes (ALKS)
NASDAQ:ALKS
US Market
ALKS
Alkermes
RESEARCH TOOLSreports

Alkermes (ALKS) Stock Forecast & Price Target

625 Followers
See the Price Targets and Ratings of:

ALKS Analyst Ratings

Strong Buy
14Ratings
Strong Buy
12 Buy
2 Hold
0 Sell
Based on 14 analysts giving stock ratings to
Alkermes
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ALKS Stock 12 Month Forecast

Average Price Target

$43.75
▲(32.50% Upside)
Based on 14 Wall Street analysts offering 12 month price targets for Alkermes in the last 3 months. The average price target is $43.75 with a high forecast of $58.00 and a low forecast of $34.00. The average price target represents a 32.50% change from the last price of $33.02.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"25":"$25","42":"$42","59":"$59","33.5":"$33.5","50.5":"$50.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":58,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$58.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":43.75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$43.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":34,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$34.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[25,33.5,42,50.5,59],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2025","6":"Oct<br/>2025","9":"Jan<br/>2026","12":"Apr<br/>2026","25":"Apr<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,35.05,36.815384615384616,38.58076923076923,40.34615384615385,42.11153846153846,43.87692307692308,45.64230769230769,47.40769230769231,49.17307692307692,50.93846153846154,52.70384615384616,54.46923076923077,56.23461538461538,{"y":58,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,35.05,35.71923076923077,36.388461538461534,37.05769230769231,37.72692307692307,38.396153846153844,39.065384615384616,39.73461538461538,40.40384615384615,41.073076923076925,41.74230769230769,42.41153846153846,43.08076923076923,{"y":43.75,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,35.05,34.96923076923077,34.888461538461534,34.80769230769231,34.72692307692307,34.646153846153844,34.565384615384616,34.48461538461538,34.40384615384615,34.323076923076925,34.24230769230769,34.16153846153846,34.08076923076923,{"y":34,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":32.53,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.58,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.29,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.985,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.55,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.4,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 44,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.65,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 49,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.7,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 61,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.9,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 46,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.98,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 58,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":34.96,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 66,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.25,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 61,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":35.05,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$58.00Average Price Target$43.75Lowest Price Target$34.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
RBC Capital Analyst forecast on ALKS
Leonid Timashev
RBC Capital
RBC Capital
$45→$44
Buy
33.25%
Upside
Reiterated
04/07/26
Alkermes price target lowered to $44 from $45 at RBC CapitalAlkermes price target lowered to $44 from $45 at RBC Capital
Stifel Nicolaus Analyst forecast on ALKS
Paul Matteis
Stifel Nicolaus
Stifel Nicolaus
$30.15→$42
Buy
27.20%
Upside
Reiterated
04/04/26
Stifel Nicolaus Keeps Their Buy Rating on Alkermes (ALKS)
TD Cowen Analyst forecast on ALKS
Joseph Thome
TD Cowen
TD Cowen
$40
Buy
21.14%
Upside
Reiterated
04/01/26
TD Cowen Sticks to Their Buy Rating for Alkermes (ALKS)
Mizuho Securities Analyst forecast on ALKS
Uy Ear
Mizuho Securities
Mizuho Securities
$45
Buy
36.28%
Upside
Reiterated
04/01/26
Mizuho Securities Sticks to Their Buy Rating for Alkermes (ALKS)
Leerink Partners Analyst forecast on ALKS
Marc Goodman
Leerink Partners
Leerink Partners
―
Hold
―
Reiterated
03/31/26
Wall Street Analysts Are Neutral on Top Healthcare Picks
Piper Sandler Analyst forecast on ALKS
David Amsellem
Piper Sandler
Piper Sandler
$45→$43
Buy
30.22%
Upside
Reiterated
03/24/26
Alkermes (ALKS) Gets a Buy from Piper Sandler
Cantor Fitzgerald Analyst forecast on ALKS
Pete Stavropoulos
Cantor Fitzgerald
Cantor Fitzgerald
$43
Buy
30.22%
Upside
Reiterated
03/11/26
Cantor Fitzgerald Remains a Buy on Alkermes (ALKS)
H.C. Wainwright Analyst forecast on ALKS
Douglas Tsao
H.C. Wainwright
H.C. Wainwright
$43
Buy
30.22%
Upside
Reiterated
03/02/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Arcellx Inc (NASDAQ: ACLX), Alkermes (NASDAQ: ALKS) and Progyny (NASDAQ: PGNY)
Truist Financial Analyst forecast on ALKS
Joon Lee
Truist Financial
Truist Financial
―
Buy
―
Reiterated
02/26/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Wells Fargo Analyst forecast on ALKS
Benjamin Burnett
Wells Fargo
Wells Fargo
$37→$43
Buy
30.22%
Upside
Reiterated
02/26/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: MannKind (NASDAQ: MNKD), Lemaitre Vascular (NASDAQ: LMAT) and Alkermes (NASDAQ: ALKS)
Bank of America Securities Analyst forecast on ALKS
Jason Gerberry
Bank of America Securities
Bank of America Securities
$34
Hold
2.97%
Upside
Reiterated
02/25/26
Balanced Risk-Reward Amid Softer 2026 Outlook Keeps Rating at Hold
Needham Analyst forecast on ALKS
Ami Fadia
Needham
Needham
$44→$45
Buy
36.28%
Upside
Reiterated
02/25/26
Alkermes: Durable Commercial Portfolio, Alixorexton Catalyst, and Orderly CEO Transition Support Buy Rating
Wolfe Research Analyst forecast on ALKS
Rudy Li
Wolfe Research
Wolfe Research
$45
Buy
36.28%
Upside
Initiated
02/23/26
Alkermes initiated with an Outperform at Wolfe ResearchAlkermes initiated with an Outperform at Wolfe Research
Jefferies Analyst forecast on ALKS
Akash Tewari
Jefferies
Jefferies
$58
Buy
75.65%
Upside
Reiterated
02/10/26
Analysts Offer Insights on Healthcare Companies: Personalis (NASDAQ: PSNL), Waters (NYSE: WAT) and Alkermes (NASDAQ: ALKS)
Deutsche Bank Analyst forecast on ALKS
David Hoang
Deutsche Bank
Deutsche Bank
$55→$45
Buy
36.28%
Upside
Reiterated
11/13/25
Alkermes (ALKS) Gets a Buy from Deutsche Bank
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
RBC Capital Analyst forecast on ALKS
Leonid Timashev
RBC Capital
RBC Capital
$45→$44
Buy
33.25%
Upside
Reiterated
04/07/26
Alkermes price target lowered to $44 from $45 at RBC CapitalAlkermes price target lowered to $44 from $45 at RBC Capital
Stifel Nicolaus Analyst forecast on ALKS
Paul Matteis
Stifel Nicolaus
Stifel Nicolaus
$30.15→$42
Buy
27.20%
Upside
Reiterated
04/04/26
Stifel Nicolaus Keeps Their Buy Rating on Alkermes (ALKS)
TD Cowen Analyst forecast on ALKS
Joseph Thome
TD Cowen
TD Cowen
$40
Buy
21.14%
Upside
Reiterated
04/01/26
TD Cowen Sticks to Their Buy Rating for Alkermes (ALKS)
Mizuho Securities Analyst forecast on ALKS
Uy Ear
Mizuho Securities
Mizuho Securities
$45
Buy
36.28%
Upside
Reiterated
04/01/26
Mizuho Securities Sticks to Their Buy Rating for Alkermes (ALKS)
Leerink Partners Analyst forecast on ALKS
Marc Goodman
Leerink Partners
Leerink Partners
―
Hold
―
Reiterated
03/31/26
Wall Street Analysts Are Neutral on Top Healthcare Picks
Piper Sandler Analyst forecast on ALKS
David Amsellem
Piper Sandler
Piper Sandler
$45→$43
Buy
30.22%
Upside
Reiterated
03/24/26
Alkermes (ALKS) Gets a Buy from Piper Sandler
Cantor Fitzgerald Analyst forecast on ALKS
Pete Stavropoulos
Cantor Fitzgerald
Cantor Fitzgerald
$43
Buy
30.22%
Upside
Reiterated
03/11/26
Cantor Fitzgerald Remains a Buy on Alkermes (ALKS)
H.C. Wainwright Analyst forecast on ALKS
Douglas Tsao
H.C. Wainwright
H.C. Wainwright
$43
Buy
30.22%
Upside
Reiterated
03/02/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Arcellx Inc (NASDAQ: ACLX), Alkermes (NASDAQ: ALKS) and Progyny (NASDAQ: PGNY)
Truist Financial Analyst forecast on ALKS
Joon Lee
Truist Financial
Truist Financial
―
Buy
―
Reiterated
02/26/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Wells Fargo Analyst forecast on ALKS
Benjamin Burnett
Wells Fargo
Wells Fargo
$37→$43
Buy
30.22%
Upside
Reiterated
02/26/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: MannKind (NASDAQ: MNKD), Lemaitre Vascular (NASDAQ: LMAT) and Alkermes (NASDAQ: ALKS)
Bank of America Securities Analyst forecast on ALKS
Jason Gerberry
Bank of America Securities
Bank of America Securities
$34
Hold
2.97%
Upside
Reiterated
02/25/26
Balanced Risk-Reward Amid Softer 2026 Outlook Keeps Rating at Hold
Needham Analyst forecast on ALKS
Ami Fadia
Needham
Needham
$44→$45
Buy
36.28%
Upside
Reiterated
02/25/26
Alkermes: Durable Commercial Portfolio, Alixorexton Catalyst, and Orderly CEO Transition Support Buy Rating
Wolfe Research Analyst forecast on ALKS
Rudy Li
Wolfe Research
Wolfe Research
$45
Buy
36.28%
Upside
Initiated
02/23/26
Alkermes initiated with an Outperform at Wolfe ResearchAlkermes initiated with an Outperform at Wolfe Research
Jefferies Analyst forecast on ALKS
Akash Tewari
Jefferies
Jefferies
$58
Buy
75.65%
Upside
Reiterated
02/10/26
Analysts Offer Insights on Healthcare Companies: Personalis (NASDAQ: PSNL), Waters (NYSE: WAT) and Alkermes (NASDAQ: ALKS)
Deutsche Bank Analyst forecast on ALKS
David Hoang
Deutsche Bank
Deutsche Bank
$55→$45
Buy
36.28%
Upside
Reiterated
11/13/25
Alkermes (ALKS) Gets a Buy from Deutsche Bank
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxx
xxx
xxx
xxx
xxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Alkermes

3 Months
xxx
Success Rate
15/19 ratings generated profit
79%
Average Return
+6.53%
reiterated a xxx
 rating 5 days ago
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 3 Months would result in 78.95% of your transactions generating a profit, with an average return of +6.53% per trade.
1 Year
Paul MatteisStifel Nicolaus
Success Rate
13/19 ratings generated profit
68%
Average Return
+17.00%
reiterated a buy rating 5 days ago
Copying Paul Matteis's trades and holding each position for 1 Year would result in 68.42% of your transactions generating a profit, with an average return of +17.00% per trade.
2 Years
xxx
Success Rate
17/24 ratings generated profit
71%
Average Return
+7.65%
reiterated a xxx
 rating 16 days ago
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 2 Years would result in 70.83% of your transactions generating a profit, with an average return of +7.65% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ALKS Analyst Recommendation Trends

Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
8
7
3
4
3
Buy
38
51
63
57
29
Hold
13
5
12
17
22
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
59
63
78
78
54
In the current month, ALKS has received 32 Buy Ratings, 22 Hold Ratings, and 0 Sell Ratings. ALKS average Analyst price target in the past 3 months is 43.75.
Each month's total comprises the sum of three months' worth of ratings.

ALKS Financial Forecast

ALKS Earnings Forecast

Next quarter’s earnings estimate for ALKS is -$0.54 with a range of -$0.93 to -$0.04. The previous quarter’s EPS was $0.29. ALKS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year ALKS has Performed in-line its overall industry.
Next quarter’s earnings estimate for ALKS is -$0.54 with a range of -$0.93 to -$0.04. The previous quarter’s EPS was $0.29. ALKS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year ALKS has Performed in-line its overall industry.

ALKS Sales Forecast

Next quarter’s sales forecast for ALKS is $362.78M with a range of $340.77M to $400.40M. The previous quarter’s sales results were $384.55M. ALKS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year ALKS has Performed in-line its overall industry.
Next quarter’s sales forecast for ALKS is $362.78M with a range of $340.77M to $400.40M. The previous quarter’s sales results were $384.55M. ALKS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year ALKS has Performed in-line its overall industry.

ALKS Stock Forecast FAQ

What is ALKS’s average 12-month price target, according to analysts?
Based on analyst ratings, Alkermes’s 12-month average price target is 43.75.
    What is ALKS’s upside potential, based on the analysts’ average price target?
    Alkermes has 32.50% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is ALKS a Buy, Sell or Hold?
          Alkermes has a consensus rating of Strong Buy which is based on 12 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Alkermes’s price target?
            The average price target for Alkermes is 43.75. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $58.00 ,the lowest forecast is $34.00. The average price target represents 32.50% Increase from the current price of $33.02.
              What do analysts say about Alkermes?
              Alkermes’s analyst rating consensus is a Strong Buy. This is based on the ratings of 14 Wall Streets Analysts.
                How can I buy shares of ALKS?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.